Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy

Clinical and Experimental Allergy

Volumn 41, Issue 2, 2011, Pages 186-191

  Miyahara, H ^a   Okazaki, N ^a   Nagakura, T ^a   Korematsu, S ^a   Izumi, T ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; CCL17; Infant; TARC; Umbilical cord blood

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA G ANTIGEN; IMMUNOGLOBULIN E; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ARTICLE; ATOPIC DERMATITIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL COUNT; FEMALE; GESTATIONAL AGE; HUMAN; INFANCY; INHERITANCE; MALE; MATERNAL AGE; MATERNAL BLOOD; MOTHER FETUS RELATIONSHIP; NEWBORN; NEWBORN ASSESSMENT; PATHOGENESIS; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UMBILICAL CORD BLOOD;

ADULT; AGE OF ONSET; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL17; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; FETAL BLOOD; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 78651417684     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03634.x     Document Type: Article

References (24)

1. Liu CA, Wang CL, Chuang H, Ou CY, Hsu TY, Yang KD. Prenatal prediction of infant atopy by maternal but not paternal total IgE levels. J Allergy Clin Immunol 2003; 112:899-904.
2. Ferguson A, Dimich-Ward H, Becker A et al. Elevated cord blood IgE is associated with recurrent wheeze and atopy at 7 yrs in a high risk cohort. Pediatr Allergy Immunol 2009; 20:710-3.
3. Matsumoto K, Shimanouchi Y, Kawakubo K et al. Infantile eczema at one month of age is associated with cord blood eosinophilia and subsequent development of atopic dermatitis and wheezing illness until two years of age. Int Arch Allergy Immunol 2005; 137 (Suppl 1):69-76.
4. Joerink M, Rindsjo E, Stenius F et al. Evidence for allergen-specific IgE of maternal origin in human placenta. Allergy 2009; 64:905-12.
5. Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005; 60:685-8.
6. Leung TF, Ng PC, Tam WH et al. Helper T-lymphocyte-related chemokines in healthy newborns. Pediatr Res 2004; 55:334-8.
7. Borres MP, Odelram H, Irander K, Kjellman NI, Bjorksten B. Peripheral blood eosinophilia in infants at 3 months of age is associated with subsequent development of atopic disease in early childhood. J Allergy Clin Immunol 1995; 95:694-8.
8. Kim JH, Kim KH, Woo HY, Shim JY. Maternal cytokine production during pregnancy and the development of childhood wheezing and allergic disease in offspring three years of age. J Asthma 2008; 45:948-52.
9. Osei-Kumah A, Smith R, Clifton VL. Maternal and cord plasma cytokine and chemokine profile in pregnancies complicated by asthma. Cytokine 2008; 43:187-93.
10. Schaub B, Liu J, Hoppler S et al. Impairment of T-regulatory cells in cord blood of atopic mothers. J Allergy Clin Immunol 2008; 121:1491-9.
11. Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki M, Yoshie O. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 1996; 271:21514-21.
12. Tsuda H, Michimata T, Hayakawa S et al. A Th2 chemokine, TARC, produced by trophoblasts and endometrial gland cells, regulates the infiltration of CCR4+T lymphocytes into human decidua at early pregnancy. Am J Reprod Immunol 2002; 48:1-8.
13. Taub DD, Lloyd AR, Conlon K et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993; 177:1809-14.
14. Poehlmann TG, Schaumann A, Busch S et al. Inhibition of term decidual NK cell cytotoxicity by soluble HLA-G1. Am J Reprod Immunol 2006; 56:275-85.
15. Hanifin JM. Atopic dermatitis in infants and children. Pediatr Clin N Am 1991; 38:763-89.
16. Hanifin JM, Cooper KD, Ho VC et al. Guidelines of care for atopic dermatitis, developed in accordance with the American academy of dermatology (AAD)/American Academy of Dermatology Association 'Administrative regulations for evidence-based clinical practice guidelines'. J Am Acad Dermatol 2004; 50:391-404.
17. Plaut M, Valentine MD. Clinical practice. Allergic rhinitis. N Engl J Med 2005; 353:1934-44.
18. Bousquet J, Clark TJ, Hurd S et al. GINA guidelines on asthma and beyond. Allergy 2007; 62:102-12.
19. Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1: Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999; 117:550-5.
20. +T cells. Eur J Immunol 1999; 29:2684-94.
21. Liddiard K, Welch JS, Lozach J, Heinz S, Glass CK, Greaves DR. Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter. BMC Mol Biol 2006; 7:45.
22. Kakinuma T, Nakamura K, Wakugawa M et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001; 107:535-41.
23. Saeki H, Tamaki K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 2006; 43:75-84.
24. Song TW, Sohn MH, Kim ES, Kim KW, Kim KE. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis. Clin Exp Allergy 2006; 36:346-51.